Catalyst Capital Advisors’s Fibrocell Science Inc. FCSC Stock Holding History

Catalyst Capital Advisors’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,965	Closed	-$134K	–	669
2015 Q4	$134K	Sell	1,965 -4,000	-67%	-$287K	0.02%	302
2015 Q3	$344K	Sell	5,965 -5,000	-46%	-$443K	0.05%	233
2015 Q2	$867K	Sell	10,965 -18,315	-63%	-$1.23M	0.1%	172
2015 Q1	$1.98M	Sell	29,280 -1,333	-4%	-$85.9K	0.23%	107
2014 Q4	$1.18M	Buy	30,613 +400	+1%	+$16.2K	0.14%	145
2014 Q3	$1.31M	Buy	30,213 +4,967	+20%	+$233K	0.17%	129
2014 Q2	$1.51M	Buy	+25,246	New	+$1.41M	0.25%	116

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Catalyst Capital Advisors's FCSC Position: Q1 2016 in Review

Catalyst Capital Advisors sold out of Fibrocell Science Inc. (FCSC) in Q1 2016, closing a stake of 1,965 shares — an estimated $134K sold.

Catalyst Capital Advisors first reported a position in FCSC in Q2 2014 and held it in 7 quarters. The position peaked at $1.98M in Q1 2015. 52 funds tracked by Wall St. Rank hold FCSC as of Q1 2016.

Catalyst Capital Advisors reported no remaining Fibrocell Science Inc. position as of Q1 2016 after selling out during the quarter.
Catalyst Capital Advisors sold 1,965 Fibrocell Science Inc. shares in Q1 2016, an estimated $134K.
Catalyst Capital Advisors first reported a position in Fibrocell Science Inc. in Q2 2014 and held it in 7 quarters.
Catalyst Capital Advisors's Fibrocell Science Inc. position peaked at $1.98M in Q1 2015.
52 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q1 2016.

Based on Catalyst Capital Advisors's 13F filing for Q1 2016, filed 11 May 2016.